According to the increasing importance of telemetric EEG registration, a miniaturized telemetry system for AC and DC transmission has been developed. The basic model has been constructed for the demands of experiments with small rodents. The transmitter is 19 X 13 X 5 mm in size and weighs 5 g including two 1.5 V batteries. The transmission of AC or DC potentials can be chosen for each channel separately. In the case of eight-channel transmission, the bandwidth ranges from 0.8 to 100 Hz, and in the case of using only one channel, signals up to a frequency of 17 kHz may be registered. Semimicroelectrodes with an electrode impedance of about 10 MΩ, as well as conventional surface electrodes can be applied. In case of long-term EEG registration of humans the total amplification at V = 1,000 has to be enlarged by using an extension module. This module consists of an additional amplification stage, a modified HF oscillator to enlarge the omnidirectional transmission sphere and external batteries to increase the operation time of the transmitter. Small dimensions, light weight and multifunctionality plead for the attractivity of this construction according to various clinical and experimental demands.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.